TC
LLY icon

Telemus Capital’s Eli Lilly LLY Stock Holding History

Telemus Capital’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$1.35M Buy
2,322
+68
+3% +$39.7K 0.11% 132
2023
Q3 		$1.21M Sell
2,254
-603
-21% -$311K 0.11% 137
2023
Q2 		$1.34M Buy
2,857
+58
+2% +$24.3K 0.11% 139
2023
Q1 		$961K Buy
2,799
+22
+0.8% +$7.42K 0.08% 168
2022
Q4 		$1.01M Buy
2,777
+31
+1% +$11K 0.09% 173
2022
Q3 		$888K Sell
2,746
-71
-3% -$22.5K 0.09% 164
2022
Q2 		$913K Buy
2,817
+716
+34% +$215K 0.09% 177
2022
Q1 		$602K Buy
2,101
+161
+8% +$41.4K 0.05% 210
2021
Q4 		$536K Buy
1,940
+12
+0.6% +$3.04K 0.04% 240
2021
Q3 		$445K Buy
1,928
+180
+10% +$44.4K 0.04% 247
2021
Q2 		$401K Sell
1,748
-3,816
-69% -$767K 0.03% 263
2021
Q1 		$1.03M Sell
5,564
-1,153
-17% -$226K 0.07% 184
2020
Q4 		$1.13M Sell
6,717
-4,875
-42% -$728K 0.08% 163
2020
Q3 		$1.69M Buy
11,592
+100
+0.9% +$15.5K 0.12% 142
2020
Q2 		$1.88M Buy
11,492
+142
+1% +$21.8K 0.15% 117
2020
Q1 		$1.74M Buy
11,350
+2,499
+28% +$343K 0.14% 125
2019
Q4 		$1.16M Buy
8,851
+302
+4% +$35K 0.09% 172
2019
Q3 		$955K Buy
8,549
+286
+3% +$31.8K 0.08% 180
2019
Q2 		$898K Sell
8,263
-203
-2% -$23.9K 0.08% 174
2019
Q1 		$1.1M Buy
8,466
+1,909
+29% +$232K 0.08% 183
2018
Q4 		$759K Buy
+6,557
New +$732K 0.06% 210
2018
Q1 		– Sell
-200
Closed -$17K – 494
2017
Q4 		$17K Buy
+200
New +$17K ﹤0.01% 478

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Telemus Capital's LLY Position: Q4 2023 in Review

Telemus Capital increased its Eli Lilly (LLY) stake by 3% in Q4 2023, buying an estimated $39.7K and bringing the position to 2,322 shares worth $1.35M. The position accounts for 0.11% of the portfolio, ranked #132.

Telemus Capital first reported a position in LLY in Q4 2017 and has held it in 22 quarters since. The position peaked at $1.88M in Q2 2020. 3,272 funds tracked by Wall St. Rank hold LLY as of Q4 2023.

  • Telemus Capital held 2,322 shares of Eli Lilly worth $1.35M as of Q4 2023.
  • Telemus Capital bought 68 Eli Lilly shares in Q4 2023, an estimated $39.7K.
  • Eli Lilly made up 0.11% of Telemus Capital's portfolio in Q4 2023, its #132 holding.
  • Telemus Capital first reported a position in Eli Lilly in Q4 2017 and has held it in 22 quarters since.
  • Telemus Capital's Eli Lilly position peaked at $1.88M in Q2 2020.
  • 3,272 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2023.

Based on Telemus Capital's 13F filing for Q4 2023, filed 1 Feb 2024.